Recent Updates
Recently added Catalysts
SEER Positive Sentiment Score: 70/100

Seer to Report Second Quarter 2025 Financial Results on August 6, 2025

Key Takeaway: Seer, Inc. has announced it will report its financial results for the second quarter of 2025 on August 6, 2025. The company will host a conference call at 1:30 p.m. PT to discuss these results, which will be available via webcast. Seer is recognized for its innovative approach in proteomics, providing insights that surpass traditional methods.

Market Sentiment Analysis

POSITIVE FACTORS

  • Seer is a pioneer in deep proteomic insights.
  • The upcoming financial results may indicate growth and progress.
  • The company is leveraging advanced technology in proteomics.

Full Press Release Details

REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday, August 6, 2025. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.
About SeerSeer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with a scale, speed, precision, and reproducibility previously unattainable. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others cannot. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visitwww.seer.bio.

Media Contact:Consort Partnerspr@seer.bio

Investor Contact:Carrie Mendivilinvestor@seer.bio

Frequently Asked Questions

When will Seer report its Q2 2025 financial results?

Seer will report its Q2 2025 financial results on August 6, 2025.

What time is Seer's conference call for financial results?

The conference call will begin at 1:30 p.m. Pacific Time.

Where can I listen to Seer's financial results webcast?

The webcast will be available on the Investor section of Seer's website.

What is Seer's focus in the biopharma industry?

Seer specializes in deep, unbiased proteomic insights.

Last updated: Jul 22, 2025